196 related articles for article (PubMed ID: 31489115)
1. Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes.
Moerman-Herzog AM; Acheampong DA; Brooks AG; Blair SM; Hsu PC; Wong HK
Oncotarget; 2019 Aug; 10(49):5052-5069. PubMed ID: 31489115
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.
Moerman-Herzog A; Mehdi SJ; Wong HK
Cells; 2020 Aug; 9(9):. PubMed ID: 32872487
[TBL] [Abstract][Full Text] [Related]
3. CD3
Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
[TBL] [Abstract][Full Text] [Related]
4. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
5. Induced Sézary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cells.
Chong BF; Dantzer P; Germeroth T; Hafner M; Wilson AJ; Xiao G; Wong HK
J Dermatol Sci; 2010 Oct; 60(1):8-20. PubMed ID: 20801618
[TBL] [Abstract][Full Text] [Related]
6. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Wong HK; Gibson H; Hake T; Geyer S; Frederickson J; Marcucci G; Caligiuri MA; Porcu P; Mishra A
J Invest Dermatol; 2015 Aug; 135(8):2084-2092. PubMed ID: 25806852
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
Hu Z; Wang W; Thakral B; Chen Z; Estrov Z; Bueso-Ramos CE; Verstovsek S; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2021 May; 100(3):352-360. PubMed ID: 32157815
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.
Ravoet M; Sibille C; Gu C; Libin M; Haibe-Kains B; Sotiriou C; Goldman M; Roufosse F; Willard-Gallo K
Blood; 2009 Oct; 114(14):2969-83. PubMed ID: 19608752
[TBL] [Abstract][Full Text] [Related]
9. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.
Ravoet M; Sibille C; Roufosse F; Duvillier H; Sotiriou C; Schandené L; Martiat P; Goldman M; Willard-Gallo KE
Haematologica; 2005 Jun; 90(6):753-65. PubMed ID: 15951288
[TBL] [Abstract][Full Text] [Related]
10. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
11. Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.
d'Elbée JM; Parrens M; Mercié P; Longy Boursier M; Dieval C; de Mascarel A; Duffau P; Dubus P; Fricain JC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e185-90. PubMed ID: 23669204
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
[TBL] [Abstract][Full Text] [Related]
13. IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.
Carruthers MN; Park S; Slack GW; Dalal BI; Skinnider BF; Schaeffer DF; Dutz JP; Law JK; Donnellan F; Marquez V; Seidman M; Wong PC; Mattman A; Chen LY
Eur J Haematol; 2017 Apr; 98(4):378-387. PubMed ID: 28005278
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.
Kohnken R; Kodigepalli KM; Mishra A; Porcu P; Wu L
Leuk Res; 2017 Jan; 52():58-66. PubMed ID: 27889686
[TBL] [Abstract][Full Text] [Related]
16. A Lymphocytic Variant of Hypereosinophilic Syndrome Presenting With Isolated Cutaneous Manifestations.
Kamal Idrissi O; Hali F; El Fatoiki F; Chiheb S
Cureus; 2022 Sep; 14(9):e29745. PubMed ID: 36340564
[TBL] [Abstract][Full Text] [Related]
17. Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.
Jones CL; Ferreira S; McKenzie RC; Tosi I; Caesar JA; Bagot M; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2012 Aug; 132(8):2042-9. PubMed ID: 22495182
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.
Jones CL; Wain EM; Chu CC; Tosi I; Foster R; McKenzie RC; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2010 Apr; 130(4):1116-25. PubMed ID: 19759548
[TBL] [Abstract][Full Text] [Related]
20. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
